Concepedia

Hojong Yoon

HY

18

Publications

947

Citations

15

H-Index

2014

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Korea Institute of Science and Technology

Broad Institute

Korea University

Hojong Yoon is an author at Dana-Farber Cancer Institute specializing in pharmacology, natural sciences, and medicine.

ORCID

Top concepts

Publications per year

2014–2025

18

Publications

18

Small-molecule-induced polymerization triggers degradation of BCL6

Mikołaj Słabicki, Hojong Yoon, Jonas Koeppel et al. · Nature · 2020 · 252 citations · Full text

, , +4

Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15

T.B. Faust, Hojong Yoon, Radosław P. Nowak et al. · Nature Chemical Biology · 2019 · 203 citations · Full text

, , +3

Exploring the target scope of KEAP1 E3 ligase-based PROTACs

Guangyan Du, Jie Jiang, Nathaniel J. Henning et al. · Cell chemical biology · 2022 · 82 citations · Full text

, , +4

Template-assisted covalent modification underlies activity of covalent molecular glues

Yen-Der Li, W Michelle, Muhammad Murtaza Hassan et al. · Nature Chemical Biology · 2024 · 64 citations · Full text

Rationally Designed Covalent BCL6 Inhibitor That Targets a Tyrosine Residue in the Homodimer Interface

Mingxing Teng, Scott B. Ficarro, Hojong Yoon et al. · ACS Medicinal Chemistry Letters · 2020 · 47 citations · Full text

Rows per page

1–5 of 18